Masked HypertensionNCT02663336
Prevalence of Masked Hypertension in Nephrological Patients
An observational study of Masked Hypertension, run by Waid City Hospital, Zurich at 1 site in Switzerland.
Trial summary
The purpose of this study is to determine the percentage of patients with masked hypertension in a population with chronic kidney disease. The investigators goal is to register prospectively ambulatory blood pressure measurement results of patients of a nephrological outpatient clinic with normal office blood pressure… Read more about this study
- Who is it for?
- Ages 20 to 90 years
- Conditions the study is for
- Masked Hypertension
- What is being tested?
- Comparison ABPM with OBPM
- How many people
- 100 participants
- Where
- 1 siteSwitzerland
- Study dates
- Dec 2015to Nov 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with chronic kidney disease of the nephrological outpatient clinic of Waidspital with normal office blood pressure in the context of diagnosed arterial hypertension with or without antihypertensive medication
Who may be able to join
- Age: 20-90 years
- Known arterial hypertension and antihypertensive medical treatment
- Office blood pressure < 140 mmHg systolic and <90 mmHg diastolic
Who cannot join
- Age <20 or >90 years
Trial locations and contacts
1 site in 1 country.
Switzerland1 site, 1 recruiting
- Recruiting
Stadtspital Waid Zurich
Zurich, 8037
About this study
The purpose of this study is to determine the percentage of patients with masked hypertension in a population with chronic kidney disease. The investigators goal is to register prospectively ambulatory blood pressure measurement results of patients of a nephrological outpatient clinic with normal office blood pressure to finally find the percentage of masked hypertension in this population.
- Conditions
- Masked Hypertension
- Being tested
- Comparison ABPM with OBPM
- Keywords
- masked hypertension, chronic kidney disease
- Medical subject headings
- Masked Hypertension, Renal Insufficiency, Chronic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Comparison ABPM with OBPMOther
No interventions
| Study group | Role | What they receive |
|---|---|---|
| CKD patients | Patients with chronic kidney disease, with diagnosed arterial hypertension and normal blood pressure during office blood pressure measurement. Comparison of ambulatory blood pressure (ABPM) with office blood pressure measurements (OBPM). Receives: Other: Comparison ABPM with OBPM |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of participants with uncontrolled masked hypertension assessed by comparison of ambulatory blood pressure with office blood pressure
Measured: 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jan 2016 (estimated)
- Study startDec 2015
- Primary completionJan 2023 (estimated)
- Study completionNov 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Masked HypertensionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Waid City Hospital, Zurich
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Andreas Schleich, Principal investigator, Stadtspital Waid Zurich Switzerland
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02663336
- Sponsor's protocol ID
- WaidBP16
- Status last verified
- Oct 2021
- First submitted
- 18 Jan 2016
- Last updated
- 28 Oct 2021
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Oct 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Masked Hypertension in Nephrological Patients
- ClinicalTrials.gov ID
- NCT02663336
- Acronym / sponsor ID
- WaidBP16
- Conditions
- Masked Hypertension
- Keywords
- masked hypertension, chronic kidney disease
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Waid City Hospital, ZurichUniversity, hospital or other
- Study start
- Dec 2015
- Primary completion
- Jan 2023 (estimated)
- Study completion
- Nov 2023 (estimated)
- First posted
- 26 Jan 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine the percentage of patients with masked hypertension in a population with chronic kidney disease. The investigators goal is to register prospectively ambulatory blood pressure measurement results of patients of a nephrological outpatient clinic with normal office blood pressure to finally find the percentage of masked hypertension in this population.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| CKD patients | – | Other: Comparison ABPM with OBPMPatients with chronic kidney disease, with diagnosed arterial hypertension and normal blood pressure during office blood pressure measurement. Comparison of ambulatory blood pressure (ABPM) with office blood pressure measurements (OBPM). |
Who may qualify
- Ages
- 20 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with chronic kidney disease of the nephrological outpatient clinic of Waidspital with normal office blood pressure in the context of diagnosed arterial hypertension with or without antihypertensive medication
Key inclusion criteria (3 listed)
- Age: 20-90 years
- Known arterial hypertension and antihypertensive medical treatment
- Office blood pressure < 140 mmHg systolic and <90 mmHg diastolic
Key exclusion criteria (1 listed)
- Age <20 or >90 years
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Comparison ABPM with OBPMNo interventions | Other | CKD patients |
Primary outcome
Number of participants with uncontrolled masked hypertension assessed by comparison of ambulatory blood pressure with office blood pressure
Time frame: 2 years
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Oct 2021.
Related trials for Masked Hypertension
RecruitingPhase 2
A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure.
Primary Open - Angle Glaucoma (POAG), Ocular Hypertension (OHT)
Enrolling by invitationObservational study
Real-World Validation of A Huawei Smartwatch for Hypertension Risk Screening in Malaysia
Hypertension, Vascular Disease Risk
Not yet recruitingObservational study
Real-World Validation of Huawei Wearable Technologies for Hypertension Risk Screening in Malaysia
Hypertension
RecruitingPhase 1/2
A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage
Glaucoma
Enrolling by invitationPhase 1/2
Topical Insulin for Glaucoma (TING2)
Open Angle Glaucoma, Primary Open Angle Glaucoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Andreas Schleich principal investigator
Stadtspital Waid Zurich Switzerland
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Masked Hypertension, run by Waid City Hospital, Zurich at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 28 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Andreas Schleich (-41 44 36621 11, Andreas.schleich@waid.zuerich.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of participants with uncontrolled masked hypertension assessed by comparison of ambulatory blood pressure with office blood pressure (time frame: 2 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2021.